Saturday 17 October 2026
Export TCMD’s income statement to Excel — free account
Tactile Systems Technology, Inc.
TCMD Healthcare Medical Devices
Tactile Systems Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $329.5 million, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 8.61%, EPS grew 142.9% and free cash flow fell 86.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
22.52
0.77
−3.31%
Follow TCMD
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
34.12 | 24.47 | 11.81 | 0.00 | 0.00 | 0.00 | 116.40 | 124.05 | 87.00 | 297.35 |
Piotroski F-Score |
8 | 6 | 7 | 4 | 3 | 3 | 3 | 5 | 6 | 6 |
Altman Z-Score |
9.61 | 4.97 | 3.97 | 2.05 | 3.20 | 12.41 | 21.93 | 30.36 | 21.55 | 8.24 |
P/S ratio |
2.01 | 1.40 | 1.19 | 0.96 | 1.80 | 4.65 | 6.74 | 5.78 | 4.70 | 1.66 |
Altman Z″-Score (non-manufacturers) |
8.52 | 6.70 | 5.40 | 1.92 | 3.35 | 6.54 | 7.69 | 9.97 | 9.91 | 9.12 |
P/FCF ratio |
16.47 | 10.72 | 9.78 | 72.06 | 1,359.61 | 1,728.54 | 0.00 | 0.00 | 1,380.00 | 22.59 |
Beneish M-Score |
(2.82) | (2.88) | (2.64) | (2.90) | (2.36) | (2.30) | (1.91) | (1.94) | (2.16) | (2.67) |
P/Operating CF |
38.35 | 25.05 | 17.79 | 61.69 | 66.94 | 172.55 | 14,350.81 | 156.19 | 123.43 | 51.89 |
P/B ratio |
3.03 | 1.89 | 1.69 | 1.96 | 2.93 | 6.97 | 11.34 | 9.31 | 7.05 | 2.35 |
Price to Tangible BV |
4.46 | 2.87 | 2.82 | 5.95 | 8.71 | 7.06 | 11.91 | 9.91 | 7.27 | 2.44 |
EV/Sales |
1.78 | 1.10 | 1.01 | 1.00 | 1.86 | 4.44 | 6.54 | 5.46 | 4.30 | 1.16 |
EV/EBITDA |
16.31 | 11.16 | 11.29 | 0.00 | 201.32 | 0.00 | 90.25 | 118.57 | 81.69 | 19.37 |
EV/Operating CF |
13.68 | 7.96 | 7.74 | 47.16 | 146.84 | 297.17 | 493.62 | 87.21 | 111.99 | 13.97 |
EV/FCF |
14.55 | 8.48 | 8.31 | 74.44 | 1,399.75 | 1,650.65 | (356.23) | (1,457.41) | 1,261.97 | 15.86 |
Quick Ratio |
3.49 | 3.78 | 2.88 | 1.44 | 2.62 | 3.83 | 4.05 | 4.48 | 4.38 | 4.11 |
Current Ratio |
4.03 | 4.36 | 3.54 | 1.86 | 3.29 | 4.63 | 5.06 | 5.29 | 5.29 | 4.66 |
Net Debt/EBITDA |
(2.76) | (2.96) | (2.00) | (1.21) | 5.77 | 42.35 | (2.79) | (6.93) | (7.64) | (8.22) |
Debt/Assets |
0.00% | 7.79% | 9.30% | 18.00% | 21.20% | 11.14% | 9.97% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.11 | 0.14 | 0.38 | 0.40 | 0.16 | 0.13 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.15 | 1.01 | 1.02 | 0.99 | 0.99 | 1.15 | 1.46 | 1.47 | 1.35 | 1.52 |
Operating CF/Net income |
2.24 | 2.40 | 1.26 | (0.29) | (0.22) | (4.51) | 0.23 | 1.36 | 0.72 | 4.31 |
Capex/Depreciation |
(0.38) | (0.37) | (0.38) | (0.30) | (0.64) | (0.85) | (1.85) | (2.63) | (2.07) | (1.04) |
Interest Coverage |
28.21 | 10.64 | 4.35 | (4.58) | — | — | — | — | — | — |
| 8.77% | 8.27% | 18.10% | (14.31%) | (9.34%) | (0.52%) | 10.87% | 8.17% | 8.84% | 6.05% | |
| 6.67% | 5.85% | 10.63% | (7.16%) | (5.65%) | (0.38%) | 8.48% | 6.77% | 7.21% | 2.94% | |
ROIC |
15.29% | 10.59% | 7.80% | (6.17%) | (0.79%) | (2.65%) | 8.83% | 4.31% | 8.44% | 14.88% |
Return on Tangible Assets |
14.76% | 11.90% | 25.82% | (29.05%) | (13.76%) | (0.60%) | 11.63% | 8.99% | 8.85% | 3.14% |
Average Days of Receivables |
48.60 | 55.98 | 57.42 | 81.09 | 86.80 | 85.53 | 64.42 | 66.33 | 65.94 | 64.77 |
Research and Development Expense of Revenue |
2.57% | 3.01% | 2.85% | 2.87% | 2.72% | 2.81% | 2.73% | 3.68% | 4.63% | 5.29% |
Selling, General and Administrative Expense of Revenue |
63.71% | 62.51% | 61.65% | 67.76% | 69.01% | 69.99% | 62.47% | 65.38% | 65.25% | 62.52% |
Intangible Assets out of Total Assets |
0.26 | 0.25 | 0.28 | 0.32 | 0.35 | 0.01 | 0.04 | 0.05 | 0.03 | 0.03 |
Share Based Compensation of Revenue |
2.54% | 2.67% | 2.75% | 3.89% | 4.89% | 5.71% | 5.18% | 5.55% | 3.88% | 2.23% |
Graham Net Nets |
0.17 | 0.24 | 0.18 | (0.06) | (0.01) | 0.09 | 0.05 | 0.08 | 0.12 | 0.36 |
Graham Number |
13.53 | 11.95 | 15.14 | 0.00 | 0.00 | 0.00 | 8.81 | 6.36 | 5.66 | 2.82 |
Earnings Yield |
2.93% | 4.09% | 8.47% | (7.51%) | (3.15%) | (0.11%) | 0.86% | 0.81% | 1.15% | 0.34% |
Free Cash Flow Yield |
6.07% | 9.33% | 10.22% | 1.39% | 0.07% | 0.06% | (0.27%) | (0.06%) | 0.07% | 4.43% |
Revenue per Share |
14.41 | 12.27 | 11.97 | 12.30 | 10.55 | 9.67 | 10.02 | 7.88 | 6.30 | 9.49 |
Operating CF per Share |
1.87 | 1.70 | 1.56 | 0.26 | 0.13 | 0.14 | 0.13 | 0.49 | 0.24 | 0.79 |
Capex per Share |
(0.11) | (0.10) | (0.11) | (0.10) | (0.12) | (0.12) | (0.32) | (0.52) | (0.22) | (0.09) |
Free Cash Flow per Share |
1.76 | 1.60 | 1.46 | 0.16 | 0.01 | 0.03 | (0.18) | (0.03) | 0.02 | 0.70 |
Cash per Share |
4.34 | 4.56 | 3.28 | 1.90 | 2.06 | 3.03 | 2.82 | 2.51 | 2.53 | 4.68 |
Shareholders Equity per Share |
9.57 | 9.07 | 8.45 | 6.05 | 6.50 | 6.45 | 5.95 | 4.89 | 4.19 | 6.69 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
9.57 | 9.07 | 8.45 | 6.05 | 6.50 | 6.45 | 5.95 | 4.89 | 4.19 | 6.69 |
Free Cash Flow |
40.28 | 38.16 | 33.37 | 3.30 | 0.28 | 0.50 | (3.48) | (0.54) | 0.37 | 6.20 |
Working Capital |
124.21 | 136.86 | 104.24 | 55.43 | 79.09 | 96.90 | 86.91 | 68.89 | 62.35 | 50.44 |
Capital Expenditures |
(2.53) | (2.50) | (2.48) | (1.91) | (2.35) | (2.29) | (5.99) | (9.55) | (3.82) | (0.83) |
Net Current Asset Value |
110.13 | 96.24 | 57.50 | (13.83) | (2.50) | 74.28 | 69.18 | 67.16 | 61.21 | 49.94 |
EV/EBIT |
20.01 | 14.58 | 15.38 | 0.00 | 0.00 | 0.00 | 118.02 | 262.72 | 120.43 | 23.00 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.07 | 0.04 | 0.01 |
Price to Operating Income |
22.66 | 18.45 | 18.10 | 0.00 | 0.00 | 0.00 | 121.66 | 278.07 | 131.70 | 32.76 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.30 | 1.21 | 1.06 | 1.03 | 0.55 | 0.39 | 0.44 | 0.76 | 0.49 | 0.51 |
Cash ROIC |
12.66% | 10.94% | 11.31% | 1.61% | 0.13% | 0.25% | (1.92%) | (0.40%) | 0.32% | 6.12% |
Accounts Receivable Turnover |
7.42 | 6.65 | 5.60 | 4.73 | 4.46 | 4.84 | 6.36 | 6.27 | 6.29 | 5.80 |
Accounts Payable Turnover |
14.95 | 12.40 | 9.53 | 9.44 | 12.98 | 13.51 | 12.34 | 8.86 | 7.23 | 6.45 |
Inventory Turnover |
4.86 | 3.70 | 3.47 | 3.34 | 3.17 | 2.89 | 3.65 | 3.73 | 3.30 | 3.72 |
Average Days of Payables |
22.84 | 27.02 | 30.65 | 51.46 | 30.64 | 28.20 | 25.39 | 44.95 | 53.50 | 60.08 |
Days of Inventory on Hand |
64.49 | 89.30 | 103.70 | 119.20 | 117.21 | 124.73 | 125.90 | 98.43 | 138.88 | 104.28 |
Average Receivables |
44.41 | 44.06 | 49.00 | 52.15 | 46.66 | 38.65 | 29.78 | 22.93 | 17.37 | 14.58 |
Average Payables |
5.31 | 6.15 | 8.32 | 7.50 | 4.61 | 4.02 | 4.48 | 4.68 | 4.01 | 3.56 |
Average Inventory |
16.35 | 20.60 | 22.83 | 21.17 | 18.89 | 18.81 | 15.12 | 11.11 | 8.80 | 6.17 |
Average Assets |
285.93 | 289.68 | 268.22 | 249.63 | 209.18 | 162.92 | 129.41 | 97.76 | 81.19 | 55.45 |
Average Common Equity |
217.75 | 205.12 | 157.52 | 124.81 | 126.49 | 118.67 | 100.93 | 81.03 | 66.21 | 27.00 |
Columns are period end dates